Clinical Trial Update: Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema [Phase 4]

View source ↗

Summary

A Phase 4 study comparing dexamethasone intravitreal implant to intravitreal aflibercept in diabetic macular edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• EYLEA (Aflibercept)
• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Diabetic Macular Edema | Phase 4 | Status: COMPLETED